Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Grant/Award of 59,701 MYGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 59,701 | n/a |
| May 22, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 671 | n/a |
| Sep 11, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 18,000 | $1.81M |
| Jun 6, 2025 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 49,796 | n/a |
| May 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Purchase | 32 | $9.2K |
| Sep 4, 2024 | MYRIAD GENETICS INC (MYGN) | Sale | 46,012 | $1.29M |
| Jun 7, 2024 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 15,695 | n/a |
| May 20, 2024 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 5,228 | n/a |
| Jun 2, 2023 | MYRIAD GENETICS INC (MYGN) | Grant/Award | 15,151 | n/a |
| May 19, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 3,454 | n/a |